Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001082906-15-000030
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-07-24 17:29:42
Reporting Period:
2015-07-22
Filing Date:
2015-07-24
Accepted Time:
2015-07-24 17:29:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1560327 Rapid7 Inc. RPD Services-Prepackaged Software (7372) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1082906 C Jay Hoag C/o Technology Crossover Ventures
528 Ramona Street
Palo Alto CA 94301
No No Yes Yes
1188444 Jr Q Jon Reynolds C/o Technology Crossover Ventures
528 Ramona Street
Palo Alto CA 94301
No No Yes Yes
1188456 John Drew C/o Technology Crossover Ventures
528 Ramona Street
Palo Alto CA 94301
No No Yes Yes
1197937 Rick Kimball C/o Technology Crossover Ventures
528 Ramona Street
Palo Alto CA 94301
No No Yes Yes
1343722 Robert Trudeau C/o Technology Crossover Ventures
528 Ramona Street
Palo Alto CA 94301
No No Yes Yes
1406509 David Yuan C/o Technology Crossover Ventures
528 Ramona Street
Palo Alto CA 94301
No No Yes Yes
1406576 C. John Rosenberg C/o Technology Crossover Ventures
528 Ramona Street
Palo Alto CA 94301
No No Yes Yes
1419272 P L Vii(A) Tcv C/o Technology Crossover Ventures
528 Ramona Street
Palo Alto CA 94301
No No Yes Yes
1420295 Tcv Vii Lp C/o Technology Crossover Ventures
528 Ramona Street
Palo Alto CA 94301
No No Yes Yes
1440008 P Christopher Marshall C/o Technology Crossover Ventures
528 Ramona Street
Palo Alto CA 94301
No No Yes Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-07-22 10,468 $0.00 10,468 No 4 C Indirect TCV VII, L.P.
Common Stock Acquisiton 2015-07-22 4,498,677 $0.00 4,509,145 No 4 C Indirect TCV VII, L.P.
Common Stock Acquisiton 2015-07-22 1,462,957 $0.00 5,972,102 No 4 C Indirect TCV VII, L.P.
Common Stock Acquisiton 2015-07-22 204,393 $16.00 6,176,495 No 4 P Indirect TCV VII, L.P.
Common Stock Acquisiton 2015-07-22 5,436 $0.00 5,436 No 4 C Indirect TCV VII (A), L.P.
Common Stock Acquisiton 2015-07-22 2,336,270 $0.00 2,341,706 No 4 C Indirect TCV VII (A), L.P.
Common Stock Acquisiton 2015-07-22 759,748 $0.00 3,101,454 No 4 C Indirect TCV VII (A), L.P.
Common Stock Acquisiton 2015-07-22 106,147 $16.00 3,207,601 No 4 P Indirect TCV VII (A), L.P.
Common Stock Acquisiton 2015-07-22 91 $0.00 91 No 4 C Indirect TCV Member Fund, L.P.
Common Stock Acquisiton 2015-07-22 38,850 $0.00 38,941 No 4 C Indirect TCV Member Fund, L.P.
Common Stock Acquisiton 2015-07-22 13,046 $0.00 51,987 No 4 C Indirect TCV Member Fund, L.P.
Common Stock Acquisiton 2015-07-22 1,960 $16.00 53,947 No 4 P Indirect TCV Member Fund, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect TCV VII, L.P.
No 4 C Indirect TCV VII, L.P.
No 4 C Indirect TCV VII, L.P.
No 4 P Indirect TCV VII, L.P.
No 4 C Indirect TCV VII (A), L.P.
No 4 C Indirect TCV VII (A), L.P.
No 4 C Indirect TCV VII (A), L.P.
No 4 P Indirect TCV VII (A), L.P.
No 4 C Indirect TCV Member Fund, L.P.
No 4 C Indirect TCV Member Fund, L.P.
No 4 C Indirect TCV Member Fund, L.P.
No 4 P Indirect TCV Member Fund, L.P.
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Preferred Stock Disposition 2015-07-22 10,468 $0.00 10,468 $0.00
Common Stock Series B Preferred Stock Disposition 2015-07-22 5,436 $0.00 5,436 $0.00
Common Stock Series B Preferred Stock Disposition 2015-07-22 91 $0.00 91 $0.00
Common Stock Series C Preferred Stock Disposition 2015-07-22 4,498,677 $0.00 4,498,677 $0.00
Common Stock Series C Preferred Stock Disposition 2015-07-22 2,336,270 $0.00 2,336,270 $0.00
Common Stock Series C Preferred Stock Disposition 2015-07-22 38,850 $0.00 38,850 $0.00
Common Stock Series D Preferred Stock Disposition 2015-07-22 849,507 $0.00 849,507 $0.00
Common Stock Series D Preferred Stock Disposition 2015-07-22 441,169 $0.00 441,169 $0.00
Common Stock Series D Preferred Stock Disposition 2015-07-22 7,576 $0.00 7,576 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. The Series B Preferred Stock automatically converted into the same number of shares of Common Stock upon the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expirationdate.
  2. This Form 4 is filed by more than one Reporting Person and is a joint filing with the Form 4 filed by Timothy P. McAdam, TCV Member Fund, L.P., Technology Crossover Management VII, L.P., and Technology Crossover Management VII, Ltd. on July 24, 2015 and relates to the same transactions.
  3. These securities are directly held by TCV VII, L.P. Timothy P. McAdam, Jay C. Hoag, Christopher P. Marshall, Jon Q. Reynolds, Jr., Richard H. Kimball, John L. Drew, Robert W. Trudeau, John C. Rosenberg and David L. Yuan (collectively, the "TCM VII Directors") are Class A Directors of Technology Crossover Management VII, Ltd. ("Management VII") and limited partners of Technology Crossover Management VII, L.P. ("TCM VII"). Management VII is the general partner of TCM VII, which is the general partner of TCV VII, L.P. The TCM VII Directors, Management VII and TCM VII may be deemed to beneficially own the securities held by TCV VII, L.P., but each of the TCM VII Directors, Management VII and TCM VII disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
  4. The Series C Preferred Stock automatically converted into the same number of shares of Common Stock upon the closing of the Issuer's initial public offering. The Series C Preferred Stock had no expirationdate.
  5. Reflects 849,507 shares that were received in connection with the automatic conversion of the Series D Preferred Stock into the same number of shares of Common Stock upon the closing of the Issuer's initial public offering and 613,450 additional shares that were received by TCV VII, L.P. upon the closing of the Issuer's initial public offering in connection with the conversion of shares of the Issuer's Series D Preferred Stock into Common Stock pursuant to the provisions of the Issuer's certificate of incorporation then in effect.
  6. These securities are directly held by TCV VII (A), L.P. The TCM VII Directors are Class A Directors of Management VII and limited partners of TCM VII. Management VII is the general partner of TCM VII, which is the general partner of TCV VII (A), L.P. The TCM VII Directors, Management VII and TCM VII may be deemed to beneficially own the securities held by TCV VII (A), L.P., but each of the TCM VII Directors, Management VII and TCM VII disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
  7. Reflects 441,169 shares that were received in connection with the automatic conversion of the Series D Preferred Stock into the same number of shares of Common Stock upon the closing of the Issuer's initial public offering and 318,579 additional shares that were received by TCV VII (A), L.P. upon the closing of the Issuer's initial public offering in connection with the conversion of shares of the Issuer's Series D Preferred Stock into Common Stock pursuant to the provisions of the Issuer's certificate of incorporation then in effect.
  8. These securities are directly held by TCV Member Fund, L.P. ("TCV MF"). The TCM VII Directors are Class A Directors of Management VII, which is a general partner of TCV MF, and limited partners of TCV MF. The TCM VII Directors and Management VII may be deemed to beneficially own the securities held by TCV MF, but the TCM VII Directors and Management VII each disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
  9. Reflects 7,576 shares that were received in connection with the automatic conversion of the Series D Preferred Stock into the same number of shares of Common Stock upon the closing of the Issuer's initial public offering and 5,470 additional shares that were received by TCV MF upon the closing of the Issuer's initial public offering in connection with the conversion of shares of the Issuer's Series D Preferred Stock into Common Stock pursuant to the provisions of the Issuer's certificate of incorporation then in effect.
  10. The Series D Preferred Stock automatically converted into the same number of shares of Common Stock upon the closing of the Issuer's initial public offering. The Series D Preferred Stock had no expirationdate.